His lab is focusing on refining the alanine-scanning assay to some crucial residues which will correctly distinguish among fibrils from neurodegenerative tauopathies. He envisions employing this streamlined assay for postmortem neuropathological analysis, And perhaps for blood screening of tauopathies.The elements that determine regardless of wheth